Jidong Jia - Search Results

Year	Number of Results
2002	7
2003	6
2004	20
2005	26
2006	15
2007	12
2008	6
2009	16
2010	12
2011	15
2012	10
2013	21
2014	16
2015	33
2016	24
2017	19
2018	39
2019	46
2020	38
2021	28
2022	47
2023	35
2024	16

1

Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments.

Chen S, Zhou J, Wu X, Meng T, Wang B, Liu H, Wang T, Zhao X, Zhao X, Kong Y, Ou X, Jia J, Sun Y, You H. Chen S, et al. Among authors: jia j. Hepatol Int. 2024 Apr 2. doi: 10.1007/s12072-024-10643-z. Online ahead of print. Hepatol Int. 2024. PMID: 38565833

2

Study of two-photon absorption and excited-state dynamics of coumarin derivatives: the effect of monomeric and dimeric structures.

Jia J, Li J, Zhang T, Lu Y, Song Y. Jia J, et al. Phys Chem Chem Phys. 2024 Apr 3;26(14):11064-11072. doi: 10.1039/d3cp06059d. Phys Chem Chem Phys. 2024. PMID: 38529570

3

Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients.

Zhao X, Wang Y, Lai R, Wang X, Yu Y, Li M, Zhao H, Ma Z, Li M, Guo T, Han X, Meng Y, Zhang M, Su Y, Hao K, Deng Y, Kong Y, Li Z, Xie Q, Xie W, Chen C, Jia J. Zhao X, et al. Among authors: jia j. Hepatol Commun. 2024 Mar 11;8(4):e0235. doi: 10.1097/HC9.0000000000000235. eCollection 2024 Apr 1. Hepatol Commun. 2024. PMID: 38466883 Free PMC article.

4

Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD.

Ren H, Xu H, Yang D, Tong X, Zhao X, Wang Q, Sun Y, Ou X, Jia J, You H, Wang Z, Yang Z. Ren H, et al. Among authors: jia j. Abdom Radiol (NY). 2024 Mar 10. doi: 10.1007/s00261-024-04207-w. Online ahead of print. Abdom Radiol (NY). 2024. PMID: 38461432

5

Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections.

Chen T, Chen G, Wang G, Treeprasertsuk S, Lesmana CRA, Lin HC, Al-Mahtab M, Chawla YK, Tan SS, Kao JH, Yuen MF, Lee GH, Alcantara-Payawal D, Nakayama N, Abbas Z, Jafri W, Kim DJ, Choudhury A, Mahiwall R, Hou J, Hamid S, Jia J, Bajaj JS, Wang F, Sarin SK, Ning Q. Chen T, et al. Among authors: jia j. Hepatol Int. 2024 Mar 9. doi: 10.1007/s12072-023-10637-3. Online ahead of print. Hepatol Int. 2024. PMID: 38460060

6

Serum Iron Overload Activates the SMAD Pathway and Hepcidin Expression of Hepatocytes via SMURF1.

Zhang N, Yang P, Li Y, Ouyang Q, Hou F, Zhu G, Zhang B, Huang J, Jia J, Xu A. Zhang N, et al. Among authors: jia j. J Clin Transl Hepatol. 2024 Mar 28;12(3):227-235. doi: 10.14218/JCTH.2023.00440. Epub 2024 Feb 4. J Clin Transl Hepatol. 2024. PMID: 38426189 Free PMC article.

7

Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.

Cooke GS, Flower B, Cunningham E, Marshall AD, Lazarus JV, Palayew A, Jia J, Aggarwal R, Al-Mahtab M, Tanaka Y, Jeong SH, Poovorawan K, Waked I, Hiebert L, Khue PM, Grebely J, Alcantara-Payawal D, Sanchez-Avila JF, Mbendi C, Muljono DH, Lesi O, Desalegn H, Hamid S, de Araujo A, Cheinquer H, Onyekwere CA, Malyuta R, Ivanchuk I, Thomas DL, Pimenov N, Chulanov V, Dirac MA, Han H, Ward JW. Cooke GS, et al. Among authors: jia j. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):346-365. doi: 10.1016/S2468-1253(23)00321-7. Epub 2024 Feb 15. Lancet Gastroenterol Hepatol. 2024. PMID: 38367629 Review.

8

GITRL impairs hepatocyte repopulation by liver progenitor cells to aggravate inflammation and fibrosis by GITR⁺CD8⁺ T lymphocytes in CDE Mice.

Li L, He Y, Liu K, Liu L, Shan S, Liu H, Ren J, Sun S, Wang M, Jia J, Wang P. Li L, et al. Among authors: jia j. Cell Death Dis. 2024 Feb 6;15(2):114. doi: 10.1038/s41419-024-06506-y. Cell Death Dis. 2024. PMID: 38321001 Free PMC article.

9

The staging of nonalcoholic fatty liver disease fibrosis: A comparative study of MR elastography and the quantitative DCE-MRI exchange model.

Ren H, Yang D, Xu H, Tong X, Zhao X, Wang Q, Sun Y, Ou X, Jia J, You H, Wang Z, Yang Z. Ren H, et al. Among authors: jia j. Heliyon. 2024 Jan 18;10(2):e24558. doi: 10.1016/j.heliyon.2024.e24558. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312594 Free PMC article.

10

Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena.

Li M, Chen S, Li S, Lv T, Li B, Shan S, Li M, Zeng N, Wang Q, Kong Y, Ma H, Zhao X, Ou X, You H, Duan W, Jia J. Li M, et al. Among authors: jia j. Therap Adv Gastroenterol. 2024 Jan 18;17:17562848231224840. doi: 10.1177/17562848231224840. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38250015 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

457 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

457 results

Results by year